Clostridium difficile: History of Its Role as an Enteric Pathogen and the Current State of Knowledge About the Organism
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is the most frequently identified enteric pathogen in patients with antibiotic-associated diarrhea and colitis. It accounts for 10%-25% of all cases of antibiotic-associated diarrhea and virtually all cases of antibiotic-associated pseudomembranous colitis. Clinical features that distinguish infection with C. difficile from that due to many other enteric pathogens are hyperpyrexia, leukemoid reactions, toxic megacolon, pseudomembranous colitis, hypoalbuminemia, and chronic diarrhea. Factors important in the pathogenesis of disease are exposure to antibiotics, the presence of C. difficile in the patient's indigenous flora or acquisition of the organism from an environmental source, production of toxin A, and age-related susceptibility. The criterion standard for testing is the tissue culture assay; alternatives are culture and other methods of antigen detection including EIA, dot blot hybridization assay, and latex agglutination. The optimal drug for treatment is vancomycin; however, metronidazole is often used because it is less expensive. At present the main problems associated with C. difficile infection are treatment of patients with ileus, the management and prevention of nosocomial epidemics, and the management of repeated relapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374 · cited 4×
“difficile antitoxin confirms infection with the organism [8, 9, 22].”
BackgroundInfluentialSelf-citationTeasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
HALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
Clindamycin-Associated Colitis: A Prospective Study
TEDESCO, F. J., BARTON, R. W., & ALPERS, D. H. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-429 · Cited by 606
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.5.701 · Cited by 472
Self-citationSUCCESSFUL TREATMENT OF RELAPSING CLOSTRIDIUM DIFFICILE COLITIS WITH LACTOBACILLUS GG
Gorbach, S., Chang, T.-W., & Goldin, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92646-8 · Cited by 464
Antibiotic-Associated Diarrhea
Bartlett, J. G. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.4.573 · Cited by 414
Self-citationViscidi, R., Willey, S., & Bartlett, J. G. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90644-2 · Cited by 412
Self-citationPurification and characterization of toxins A and B of Clostridium difficile
Sullivan, N. M., Pellett, S., & Wilkins, T. D. (1982) · Infection and Immunity · doi:10.1128/iai.35.3.1032-1040.1982 · Cited by 368
Johnson, S., Homann, S. R., Bettin, K. M., Quick, J. N., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-297 · Cited by 355
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Bolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Johnson, S., Gerding, D. N., Olson, M. M., Weiler, M. D., Hughes, R. A., Clabots, C. R., & Peterson, L. R. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90462-m · Cited by 317
Comparison of two toxins produced by Clostridium difficile
Taylor, N. S., Thorne, G. M., & Bartlett, J. G. (1981) · Infection and Immunity · doi:10.1128/iai.34.3.1036-1043.1981 · Cited by 294
Self-citationFekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Undescribed toxin in pseudomembranous colitis.
Larson, H. E., Parry, J. V., Price, A. B., Davies, D. R., Dolby, J., & Tyrrell, D. A. (1977) · BMJ · doi:10.1136/bmj.1.6071.1246 · Cited by 256
Aronsson, B., Mollby, R., & Nord, C. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.476 · Cited by 245
Cytotoxicity Assay in Antibiotic-Associated Colitis
Chang, T.-W., Lauermann, M., & Bartlett, J. G. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.5.765 · Cited by 220
Self-citationApproach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Tedesco, F. J., Gordon, D., & Fortson, W. C. (1985) · PubMed · Cited by 217
Serum Antibody Response to Toxins A and B of Clostridium difficile
Viscidi, R., Laughon, B. E., Yolken, R., Bo-Linn, P., Moench, T., Ryder, R. W., & Bartlett, J. G. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.1.93 · Cited by 204
Self-citationRelapsing Clostridium difficile Enterocolitis Cured by Rectal Infusion of Normal Faeces
Schwan, A., Sjolin, S., Trottestam, U., & Aronsson, B. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087145 · Cited by 201
IS CLOSTRIDIUM DIFFICILE ENDEMIC IN CHRONIC-CARE FACILITIES?
Bender, B., Laughon, B., Gaydos, C., Forman, M., Bennett, R., Greenough, W. B., Sears, S., & Bartlett, J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92559-6 · Cited by 184
Self-citationTreatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Surawicz, C. M., McFarland, L. V., Elmer, G., & Chinn, J. (1989) · PubMed · Cited by 179
Young, G. P., Ward, P. B., Bayley, N., Gordon, D., Higgins, G., Trapani, J. A., McDonald, M. I., Labrooy, J., & Hecker, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90206-9 · Cited by 171
Lima, A. A., Lyerly, D. M., Wilkins, T. D., Innes, D. J., & Guerrant, R. L. (1988) · Infection and Immunity · doi:10.1128/iai.56.3.582-588.1988 · Cited by 170
Clinical and laboratory observations in Clostridium difficile colitis
Bartlett, J. G., Taylor, N. S., Chang, T., & Dzink, J. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.11.2521 · Cited by 162
Self-citationPseudomembranous colitis: CT evaluation of 26 cases.
Fishman, E. K., Kavuru, M. S., Jones, B., Kuhlman, J. E., Merine, D. S., Lillimoe, K. D., & SIEGELMAN, S. S. (1991) · Radiology · doi:10.1148/radiology.180.1.2052723 · Cited by 152
Barbut, F., Kajzer, C., Planas, N., & Petit, J. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.963-967.1993 · Cited by 142
Borriello, S. P., Wren, B. W., Hyde, S., Seddon, S. V., Sibbons, P., Krishna, M. M., Tabaqchali, S., Manek, S., & Price, A. B. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4192-4199.1992 · Cited by 140
Investigation of an outbreak of antibiotic-associated colitis by various typing methods
Wüst, J., Sullivan, N. M., Hardegger, U., & Wilkins, T. D. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.16.6.1096-1101.1982 · Cited by 139
TYPING SCHEME FOR CLOSTRIDIUM DIFFICILE: ITS APPLICATION IN CLINICAL AND EPIDEMIOLOGICAL STUDIES
Tabaqchali, S., O'Farrell, S. M., Holland, D. T., & Silman, R. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92392-4 · Cited by 128
Clindamycin-Associated Colitis in Hamsters: Protection with Vancomycin
Bartlett, J. G., Onderdonk, A. B., & Cisneros, R. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)31782-2 · Cited by 125
Self-citationBuggy, B. P., Fekety, R., & Silva, J. (1987) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198704000-00009 · Cited by 119
Lyerly, D. M., Barroso, L. A., & Wilkins, T. D. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.11.2639-2642.1991 · Cited by 116
THE TOXICITY OF PENICILLIN AS PREPARED FOR CLINICAL USE
Hamre, D. M., Rake, G. W., McKee, C. M., & MacPhillamy, H. B. (1943) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194311000-00011 · Cited by 113
Enzyme Immunoassays for Detection of Clostridium difficile Toxins A and B in Fecal Specimens
Laughon, B. E., Viscidi, R. P., Gdovin, S. L., Yolken, R. H., & Bartlett, J. G. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/149.5.781 · Cited by 109
Self-citationAntimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis.
Bartlett, J. G. (1981) · PubMed · Cited by 108
Self-citationStaphylococcal Enterocolitis—Treatment with Oral Vancomycin
Khan, M. Y., & HALL, W. H. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-65-1-1 · Cited by 107
Specific detection of toxigenic strains of Clostridium difficile in stool specimens
Gumerlock, P. H., Tang, Y. J., Weiss, J., & Silva, J. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.3.507-511.1993 · Cited by 106
Pseudomembranous enterocolitis (antibiotic-related colitis).
Bartlett, J. G., & Sl, G. (1977) · PubMed · Cited by 101
Self-citationDzink-Fox, J., & Bartlett, J. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.4.695 · Cited by 98
Self-citationSystemic and Mucosal Antibody Responses to Toxin A in Patients Infected with Clostridium difficile
Johnson, S., Gerding, D. N., & Janoff, E. N. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1287 · Cited by 98
Kuijper, E. J., Oudbier, J. H., Stuifbergen, W. N. H. M., Jansz, A. R., & Zanen, H. C. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.4.751-753.1987 · Cited by 92
Disease Associated with Clostridium difficile Infection
Gerding, D. N. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-4-255 · Cited by 84
OCCURRENCE OF CLOSTRIDIUM DIFFICILE IN INFECTIONS OF MAN
Smith, L. D., & King, E. O. (1962) · Journal of Bacteriology · doi:10.1128/jb.84.1.65-67.1962 · Cited by 82
McFarland, L. V., Elmer, G. W., Stamm, W. E., & Mulligan, M. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.7.2456-2462.1991 · Cited by 72
Further Studies on Bacillus Difficilis (Hall and O'Toole)
Snyder, M. L. (1937) · The Journal of Infectious Diseases · doi:10.1093/infdis/60.2.223 · Cited by 55
The association of viral activation with penicillin toxicity in guinea pigs and hamsters.
Green, R. H. (1974) · PubMed Central · Cited by 51
Clabots, C., Peterson, L. R., & Gerding, D. N. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.731 · Cited by 47
Treatment of antibiotic-associated colitis with vancomycin
Fekety, R., Silva, J., Buggy, B. P., & Deery, H. G. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.97 · Cited by 43
Fusidic acid for the treatment of antibiotic-associated colitis induced by clostridium difficile
Cronberg, S., Castor, B., & Thorén, A. (1984) · Infection · doi:10.1007/bf01645961 · Cited by 41
Is Clostridium difficile pathogenic in infants?
Welch, D. F., & Marks, M. I. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80436-8 · Cited by 36
Bacterial Agglutination and Polyacrylamide Gel Electrophoresis for Typing Clostridium difficile
Mulligan, M. E., Halebian, S., Kwok, R. Y. Y., Cheng, W. C., Finegold, S. M., Anselmo, C. R., Gerding, D. N., & Peterson, L. R. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.2.267 · Cited by 23
Woods, G. L., & Iwen, P. C. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.5.855-857.1990 · Cited by 22
Cited by
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
O’Grady, N. P., Barie, P. S., Bartlett, J. G., Bleck, T., Carroll, K., Kalil, A. C., Linden, P., Maki, D. G., Nierman, D., Pasculle, W., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318169eda9 · Cited by 600
Self-citationClinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Self-citation
Metadata
- Authors
- Bartlett, J. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-05-01
- Volume
- 18
- Issue
- Supplement_4
- Pages
- S265-S272
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2074934442
- Cited by
- 309
- References
- 56
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.